CDI – HISS

3 January, 2026

A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection

2026-10-14T11:51:59+03:00By hiss|Categories: Publications, Therapeutics|Tags: bezlotoxumab, CDI, microbiome|

Cell Reports Medicine, January 2, 2026

We use necessary cookies to make our website work properly and to store your choices in relation to optional cookies.
I want to be informed about the Cookies Policy

OK